<DOC>
	<DOCNO>NCT02661438</DOCNO>
	<brief_summary>The rationale study conduct summative ( i.e. , validation ) usability test Ciprofloxacin Dry Powder Inhalation ( DPI ) associate Instructions Use .</brief_summary>
	<brief_title>Summative Usability Study Ciprofloxacin Dry Powder Inhalation Using Placebo</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Inclusion Criteria Subjects ( male female ) noncystic fibrosis bronchiectasis ( NCFB ) chronic obstructive pulmonary disease ( COPD ) Subjects must age â‰¥40 Subject must able independently manage administer NCFB/COPD medication Subjects recent exacerbation Subjects recent significant hemoptysis four week screen ( and/or screen period ) Subjects allergic quinine Known chronic bronchial asthma</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Usability Test</keyword>
</DOC>